HTFL — HEARTFLOW INC
Healthcare · ETF XLV · as of 2026-09-18
Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ
HEARTFLOW INC
Healthcare · Health Information Services
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Price & today
$50.75
ATR(14) 2.49 (4.90%)
| Stock today | +2.38% |
| Sector ETF today | -0.25% |
| Residual (stock-specific) | +2.63% |
Sector correlation
| 20-day correlation with XLV | 0.34 |
| 60-day correlation with XLV | 0.08 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $48.90 |
| 20 EMA | $47.01 |
| 50 EMA | $40.92 |
| EMA stack | BULLISH |
| RSI(14) | 67.5 |
| 52-week high distance | +23.12% |
| 52-week low distance | +152.11% |
Signals
| Market F&G | 46.9 |
| Bull% | 12.2% |
| OVTLYR status | — |
| Sector rank | — |
| Next earnings | 2026-11-10 (TNS, 52d) |
MarketSmith metrics - our compute
RS Rating
98.2
ADR%
5.1
RMV (tight)
27.0
Ext (ATR>20EMA)
1.5
Rel Vol
359.0%
U/D 50d
1.38
U/D 25d
1.43
Accum/Dist 25d
10 / 4
EPS YoY
+94.0%
LoD dist
59.0
Off 52w High
2.8%
Above 52w Low
152.1%
1W / 1M
+1.7 / +11.5
Avg $Vol 50d
76.2M
Mkt Cap (B)
4.4
Trend 8/8
YES
Leads Group
YES
Sector XLV
+1.8% 1W
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
P/E (TTM)
-
Fwd P/E
-
PEG
-
Price/Book
8.7
Profit margin
-58.4%
ROE
-135.3%
Debt/Equity
9.2
Rev growth
+41.3%
Analyst target
$37 (-28%)
Analyst rating
STRONG_BUY
Institutional %
84.9%
Insider %
5.3%
Float %
76.8%
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.
Company data - context read, not entry inputs
Industry rank
14 / 147
Industry
Health Information Services
Float
66.2M
Float turnover 20d
3.2%
Avg $Vol 20d / 50d
106.1M / 76.2M
Days to cover
2.7
Short % float
9.9%
Institutional %
84.9%
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.
Quarterly EPS - earnings acceleration
A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Sep-25 | -1.10 | - | 43.4 | - |
| Nov-25 | -0.27 | - | 46.3 | - |
| Mar-26 | -0.12 | - | 49.1 | - |
| May-26 | -0.16 | - | 52.6 | - |
| Aug-26 | -0.07 | - | 64.1 | +48% |
† = SEC carries this same fiscal quarter under a second period-end with a materially different figure (hover for it) - a restatement, merger recast or successor-period split; %Chg is blanked when the two are more than 15% apart. It fires only when the two period-ends DISAGREE, so it is a floor, not a guarantee that the rest of the column shares one basis · ‡ = the revenue concept changed from the previous quarter WITH A FIGURE (hover for both) - a blank row in between is skipped, as the eye does - a step at that row is a change of basis, not necessarily of business · EPS = Yahoo
eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).Recent news - our DB (Finnhub + OVTLYR)
- Sep 17 · BCSM Exits Heartflow (HTFL) on Competitive Concerns Yahoo
- Sep 17 + Software as a Medical Device Market Set for Rapid Growth Through 2034 as AI Innovation, Digital Health Adoption, and Regulatory Advances Reshape the Competitive Landscape GlobeNewswire Inc.
- Sep 15 · HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High The Motley Fool
- Sep 15 · HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High Yahoo
- Sep 11 · HeartFlow, Inc. (HTFL) Presents at Wells Fargo 21st Annual Healthcare Conference - Slideshow SeekingAlpha
- Sep 09 · UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55 Benzinga
- Sep 06 − HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High The Motley Fool
- Sep 04 · Baron SMID Cap ETF Q2 2026 Portfolio Activity Seeking Alpha